Immunogenicity of two doses of <scp>BNT162b2</scp> and <scp>mRNA</scp> ‐1273 vaccines for solid cancer patients on treatment with or without a previous <scp>SARS‐CoV</scp> ‐2 infection-Reference-Cited by-同舟云学术

Immunogenicity of two doses of BNT162b2 and mRNA ‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV ‐2 infection

Published:2022-09-28 Issue:4 Volume:152 Page:661-671
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

La Verde Nicla¹,Riva Agostino²³,Cona Maria Silvia¹^ORCID,Gabrieli Arianna³,Cattaneo Monica¹,Fasola Cinzia¹,Lipari Giuseppe³,De Stradis Claudia³,Favorito Valentina¹,Lombardi Stocchetti Benedetta¹,Chizzoniti Davide¹,Covizzi Alice²,Rulli Eliana⁴,Galli Francesca⁴,Ruggieri Lorenzo¹,Gambaro Anna¹,Ferrario Sabrina¹,Dalu Davide¹,Tarkowski Maciej S.³

Affiliation:

1. Department of Oncology Sacco Hospital, ASST Fatebenefratelli Sacco Milan Italy

2. Department of Infectious Diseases Sacco Hospital, ASST Fatebenefratelli Sacco Milan Italy

3. Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC University of Milan Milan Italy

4. Laboratory of Methodology for Clinical Research Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34273

Reference45 articles.

1. WHO declares COVID‐19 a pandemic;Cucinotta D;Acta Biomed,2020

2. MERS coronavirus outbreak: Implications for emerging viral infections

3. Molecular epidemiology, evolution and phylogeny of SARS coronavirus

4. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

5. Italy's first wave of the COVID-19 pandemic has ended: no excess mortality in May, 2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Humoral immune response as an indicator for protection against Covid‐19 after anti‐SARS‐COV2‐booster vaccination in hematological and oncological patients;International Journal of Cancer;2024-09-02

2. Antibody response to three‐dose anti‐SARS‐CoV‐2 mRNA‐vaccination in treated solid cancer patients;International Journal of Cancer;2023-12-15

3. Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM);ESMO Open;2023-06

4. Clinical efficacy of the first two doses of anti‐SARS‐CoV‐2 mRNA vaccines in solid cancer patients;Cancer Medicine;2023-04-28

5. Immune responses to inactivated COVID-19 vaccine were decreased in Chinese patients with chronic respiratory diseases;International Journal of Medical Sciences;2023